-
-
(2S，3S，4R，5R，6R)-5-Amino-2-(aminomethyl)-6-(((2R，3S，4R，5S)-5-(((1R，2R，3S，5R，6S)-3，5-diamino-2-(((2R，3R，4R，5S，6R)-3-amino-6-(aminomethyl)-4，5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)ox,650 IU/mg(on dried basis), 500g
-
NFAT inhibitor,95%, 1mg
-
NFAT inhibitor,95%, 5mg
-
NFAT inhibitor,95%, 25mg
-
2-((6-Amino-3，5-dicyano-4-(4-(cyclopropylmethoxy)
phenyl)pyridin-2-yl)thio)acetamide,≥98%(HPLC), 5mg
-
2-((6-Amino-3，5-dicyano-4-(4-(cyclopropylmethoxy)
phenyl)pyridin-2-yl)thio)acetamide,≥98%(HPLC), 10mg
-
2-((6-Amino-3，5-dicyano-4-(4-(cyclopropylmethoxy)
phenyl)pyridin-2-yl)thio)acetamide,≥98%(HPLC), 25mg
-
4-Cyano-N-(1，3-dimethyl-2-oxo-1，2-dihydroquinolin-6-yl)benzenesulfonamide,98%, 5mg
-
4-Cyano-N-(1，3-dimethyl-2-oxo-1，2-dihydroquinolin-6-yl)benzenesulfonamide,98%, 10mg
-
4-Cyano-N-(1，3-dimethyl-2-oxo-1，2-dihydroquinolin-6-yl)benzenesulfonamide,98%, 25mg
-
N-[5-[5-(2，4-Dioxo-1，3，8-triazaspiro[4.5]dec-8-yl)-1-oxopentyl]-2，4-dimethoxy
phenyl]-4-(trifluoromethyl)-benzenesulfonamidehydrochloride,97%, 100mg
стр.: